Additional European Equity News
GSK (GSK LN) - Headline results from Phase 3 first trial; Jemperli added to chemo shows significant effect on PFS. (Newswires)
IDS (IDS LN) - EP Corporate welcomes the announcement by Chancellor of Duchy of Lancaster that he has given notice of final order in relation to IDS offer; IDS and Bidco considered approval condition and determined to be reasonable acceptable. (Newswires)
Spie (SPIE FP) - Announces the acquisition of Anyllinq in Netherlands. (Newswires)
UK Supermarkets - ONS says "For the first time in three months there was a boost for food store sales, particularly supermarkets". (Newswires)
Teamviewer (TMV GY) downgraded to Neutral from Buy at Goldman Sachs
20 Dec 2024 - 07:02- EquitiesResearch Sheet- Source: Newsquawk
Subscribe Now to Newsquawk
Click here for a 1 week free trial
Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include:
- Real-time audio coverage from 0630 to 2200 London time plus Asia-Pac 2200 to 1000 London time
- Teams of analysts covering equities, fixed income, FX, energy, and metals markets
- Real-time scrolling news service with instant analysis
- Daily and weekly pre-market research and calendars
- Video updates covering near-term key risk events & primary trading themes
- One-to-one chat with our expert analysts